Your browser doesn't support javascript.
loading
Trends in lipid-modifying agent use in 83 countries.
Blais, Joseph E; Wei, Yue; Yap, Kevin K W; Alwafi, Hassan; Ma, Tian-Tian; Brauer, Ruth; Lau, Wallis C Y; Man, Kenneth K C; Siu, Chung Wah; Tan, Kathryn C B; Wong, Ian C K; Wei, Li; Chan, Esther W.
Afiliación
  • Blais JE; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong.
  • Wei Y; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong.
  • Yap KKW; Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong.
  • Alwafi H; Research Department of Practice and Policy, UCL School of Pharmacy, London, UK; Faculty of Medicine, Umm Al Qura University, Mecca, Saudi Arabia.
  • Ma TT; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong; Research Department of Practice and Policy, UCL School of Pharmacy, London, UK; Laboratory of Data Discovery for Health, Hong Kong Science Park, Hon
  • Brauer R; Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.
  • Lau WCY; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong; Research Department of Practice and Policy, UCL School of Pharmacy, London, UK; Laboratory of Data Discovery for Health, Hong Kong Science Park, Hon
  • Man KKC; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong; Research Department of Practice and Policy, UCL School of Pharmacy, London, UK; Laboratory of Data Discovery for Health, Hong Kong Science Park, Hon
  • Siu CW; Division of Cardiology, Department of Medicine, University of Hong Kong, Hong Kong.
  • Tan KCB; Department of Medicine, University of Hong Kong, Hong Kong.
  • Wong ICK; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong; Research Department of Practice and Policy, UCL School of Pharmacy, London, UK; Laboratory of Data Discovery for Health, Hong Kong Science Park, Hon
  • Wei L; Research Department of Practice and Policy, UCL School of Pharmacy, London, UK; Laboratory of Data Discovery for Health, Hong Kong Science Park, Hong Kong.
  • Chan EW; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, University of Hong Kong, Hong Kong; Laboratory of Data Discovery for Health, Hong Kong Science Park, Hong Kong; The University of Hong Kong Shenzhen Institute of Research and Innovatio
Atherosclerosis ; 328: 44-51, 2021 07.
Article en En | MEDLINE | ID: mdl-34091069
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Anticolesterolemiantes Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Atherosclerosis Año: 2021 Tipo del documento: Article País de afiliación: Hong Kong Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Anticolesterolemiantes Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Atherosclerosis Año: 2021 Tipo del documento: Article País de afiliación: Hong Kong Pais de publicación: Irlanda